{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:39:38Z","timestamp":1790617178043,"version":"4.1.0"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,5,27]],"date-time":"2018-05-27T00:00:00Z","timestamp":1527379200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["SAF-2014-57160R"],"award-info":[{"award-number":["SAF-2014-57160R"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["SAF2015-67474-R"],"award-info":[{"award-number":["SAF2015-67474-R"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MINECO\/FEDER"},{"name":"CIBERNED"},{"DOI":"10.13039\/100005725","name":"CHDI Foundation","doi-asserted-by":"publisher","award":["A-3468"],"award-info":[{"award-number":["A-3468"]}],"id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s12035-018-1126-5","type":"journal-article","created":{"date-parts":[[2018,5,26]],"date-time":"2018-05-26T19:02:16Z","timestamp":1527361336000},"page":"935-953","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Early Downregulation of p75NTR by Genetic and Pharmacological Approaches Delays the Onset of Motor Deficits and Striatal Dysfunction in Huntington\u2019s Disease Mice"],"prefix":"10.1007","volume":"56","author":[{"given":"Nuria","family":"Suelves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Miguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saray","family":"L\u00f3pez-Benito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo Garc\u00eda-D\u00edaz","family":"Barriga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Giralt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Alvarez-Periel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Ar\u00e9valo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Alberch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Gin\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,27]]},"reference":[{"key":"1126_CR1","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker FO (2007) Huntington\u2019s disease. Lancet 369:218\u2013228","journal-title":"Lancet"},{"key":"1126_CR2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington\u2019s Disease Collaborative Research Group","year":"1993","unstructured":"The Huntington\u2019s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72:971\u2013983","journal-title":"Cell"},{"key":"1126_CR3","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EPJ (1985) Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol 44:559\u2013577","journal-title":"J Neuropathol Exp Neurol"},{"key":"1126_CR4","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277:1990\u20131993","journal-title":"Science"},{"key":"1126_CR5","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.1523\/JNEUROSCI.19-13-05409.1999","volume":"19","author":"S Ivkovic","year":"1999","unstructured":"Ivkovic S, Ehrlich ME (1999) Expression of the striatal DARPP-32\/ARPP-21 phenotype in GABAergic neurons requires neurotrophins in vivo and in vitro. J Neurosci 19:5409\u20135419","journal-title":"J Neurosci"},{"key":"1126_CR6","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1073\/pnas.1004744108","volume":"108","author":"M Baydyuk","year":"2011","unstructured":"Baydyuk M, Russell T, Liao G-Y, Zang K, An JJ, Reichardt LF, Xu B (2011) TrkB receptor controls striatal formation by regulating the number of newborn striatal neurons. Proc Natl Acad Sci U S A 108:1669\u20131674","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5529","key":"1126_CR7","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","volume":"293","author":"C. Zuccato","year":"2001","unstructured":"Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, Conti L, MacDonald ME, Friedlander RM et al (2001) Loss of huntingtin-mediated BDNF gene transcription in Huntington\u2019s disease. Science 293:493\u2013498","journal-title":"Science"},{"issue":"1","key":"1126_CR8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","volume":"118","author":"Laurent R Gauthier","year":"2004","unstructured":"Gauthier LR, Charrin BC, Borrell-Pages M, Dompierre JP, Rangone H, Cordelieres FP, De Mey J, MacDonald ME et al (2004) Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118:127\u2013138","journal-title":"Cell"},{"key":"1126_CR9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrneurol.2009.54","volume":"5","author":"C Zuccato","year":"2009","unstructured":"Zuccato C, Cattaneo E (2009) Brain-derived neurotrophic factor in neurodegenerative diseases. Nat Rev Neurol 5:311\u2013322","journal-title":"Nat Rev Neurol"},{"key":"1126_CR10","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.nbd.2015.08.008","volume":"82","author":"Q Ma","year":"2015","unstructured":"Ma Q, Yang J, Li T, Milner TA, Hempstead BL (2015) Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington\u2019s disease. Neurobiol Dis 82:466\u2013477","journal-title":"Neurobiol Dis"},{"key":"1126_CR11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1471-4159.2007.05137.x","volume":"105","author":"K Gharami","year":"2008","unstructured":"Gharami K, Xie Y, An JJ, Tonegawa S, Xu B (2008) Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington\u2019s disease phenotypes in mice. J Neurochem 105:369\u2013379","journal-title":"J Neurochem"},{"issue":"10","key":"1126_CR12","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/gt.2010.71","volume":"17","author":"A Giralt","year":"2010","unstructured":"Giralt A, Friedman HC, Caneda-Ferron B, Urban N, Moreno E, Rubio N, Blanco J, Peterson A et al (2010) BDNF regulation under GFAP promoter provides engineered astrocytes as a new approach for long-term protection in Huntington\u2019s disease. Gene Ther 17:1294\u20131308","journal-title":"Gene Therapy"},{"key":"1126_CR13","doi-asserted-by":"crossref","first-page":"14708","DOI":"10.1523\/JNEUROSCI.1637-10.2010","volume":"30","author":"Y Xie","year":"2010","unstructured":"Xie Y, Hayden MR, Xu B (2010) BDNF overexpression in the forebrain rescues Huntington\u2019s disease phenotypes in YAC128 mice. J Neurosci 30:14708\u201314718","journal-title":"J Neurosci"},{"issue":"48","key":"1126_CR14","doi-asserted-by":"crossref","first-page":"18712","DOI":"10.1523\/JNEUROSCI.1310-13.2013","volume":"33","author":"D. A. Simmons","year":"2013","unstructured":"Simmons DA, Belichenko NP, Yang T, Condon C, Monbureau M, Shamloo M, Jing D, Massa SM et al (2013) A small molecule TrkB ligand reduces motor impairment and neuropathology in R6\/2 and BACHD mouse models of Huntington\u2019s disease. J Neurosci 33:18712\u201318727","journal-title":"Journal of Neuroscience"},{"key":"1126_CR15","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1460-9568.2006.04590.x","volume":"23","author":"S Gines","year":"2006","unstructured":"Gines S, Bosch M, Marco S, Gavalda N, Diaz-Hernandez M, Lucas JJ, Canals JM, Alberch J (2006) Reduced expression of the TrkB receptor in Huntington\u2019s disease mouse models and in human brain. Eur J Neurosci 23:649\u2013658","journal-title":"Eur J Neurosci"},{"key":"1126_CR16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1750-3639.2007.00111.x","volume":"18","author":"C Zuccato","year":"2008","unstructured":"Zuccato C, Marullo M, Conforti P, MacDonald ME, Tartari M, Cattaneo E (2008) Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington\u2019s disease. Brain Pathol 18:225\u2013238","journal-title":"Brain Pathol"},{"key":"1126_CR17","doi-asserted-by":"crossref","first-page":"21537","DOI":"10.1074\/jbc.M109.084202","volume":"285","author":"S Gines","year":"2010","unstructured":"Gines S, Paoletti P, Alberch J (2010) Impaired TrkB-mediated ERK1\/2 activation in Huntington disease knock-in striatal cells involves reduced p52\/p46 Shc expression. J Biol Chem 285:21537\u201321548","journal-title":"J Biol Chem"},{"key":"1126_CR18","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.1523\/JNEUROSCI.2033-12.2013","volume":"33","author":"G Liot","year":"2013","unstructured":"Liot G, Zala D, Pla P, Mottet G, Piel M, Saudou F (2013) Mutant huntingtin alters retrograde transport of TrkB receptors in striatal dendrites. J Neurosci 33:6298\u20136309","journal-title":"J Neurosci"},{"key":"1126_CR19","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.116","volume":"4","author":"V Brito","year":"2013","unstructured":"Brito V, Puigdellivol M, Giralt A, del Toro D, Alberch J, Gines S (2013) Imbalance of p75(NTR)\/TrkB protein expression in Huntington\u2019s disease: implication for neuroprotective therapies. Cell Death Dis 4:e595","journal-title":"Cell Death Dis"},{"issue":"1","key":"1126_CR20","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2014.05.032","volume":"83","author":"Joshua\u00a0L. Plotkin","year":"2014","unstructured":"Plotkin JL, Day M, Peterson JD, Xie Z, Kress GJ, Rafalovich I, Kondapalli J, Gertler TS et al (2014) Impaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington\u2019s disease. Neuron 83:178\u2013188","journal-title":"Neuron"},{"key":"1126_CR21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fncel.2016.00037","volume":"10","author":"KQ Nguyen","year":"2016","unstructured":"Nguyen KQ, Rymar VV, Sadikot AF (2016) Impaired TrkB signaling underlies reduced BDNF-mediated trophic support of striatal neurons in the R6\/2 mouse model of Huntington\u2019s disease. Front Cell Neurosci 10:37","journal-title":"Front Cell Neurosci"},{"key":"1126_CR22","first-page":"1","volume":"12","author":"SJ Baker","year":"1996","unstructured":"Baker SJ, Reddy EP (1996) Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12:1\u20139","journal-title":"Oncogene"},{"key":"1126_CR23","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0896-6273(00)81114-9","volume":"24","author":"T Yamashita","year":"1999","unstructured":"Yamashita T, Tucker KL, Barde YA (1999) Neurotrophin binding to the p75 receptor modulates rho activity and axonal outgrowth. Neuron 24:585\u2013593","journal-title":"Neuron"},{"key":"1126_CR24","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0301-0082(02)00016-3","volume":"67","author":"PP Roux","year":"2002","unstructured":"Roux PP, Barker PA (2002) Neurotrophin signaling through the p75 neurotrophin receptor. Prog Neurobiol 67:203\u2013233","journal-title":"Prog Neurobiol"},{"key":"1126_CR25","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nn1045","volume":"6","author":"T Yamashita","year":"2003","unstructured":"Yamashita T, Tohyama M (2003) The p75 receptor acts as a displacement factor that releases rho from rho-GDI. Nat Neurosci 6:461\u2013467","journal-title":"Nat Neurosci"},{"key":"1126_CR26","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1523\/JNEUROSCI.18-09-03273.1998","volume":"18","author":"SO Yoon","year":"1998","unstructured":"Yoon SO, Casaccia-Bonnefil P, Carter B, Chao MV (1998) Competitive signaling between TrkA and p75 nerve growth factor receptors determines cell survival. J Neurosci 18:3273\u20133281","journal-title":"J Neurosci"},{"key":"1126_CR27","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/460543","volume":"2011","author":"AM Fortress","year":"2011","unstructured":"Fortress AM, Buhusi M, Helke KL, Granholm A-CE (2011) Cholinergic degeneration and alterations in the TrkA and p75NTR balance as a result of pro-NGF injection into aged rats. J Aging Res 2011:460543","journal-title":"J Aging Res"},{"issue":"10","key":"1126_CR28","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1172\/JCI74809","volume":"124","author":"Ver\u00f3nica Brito","year":"2014","unstructured":"Brito V, Giralt A, Enriquez-Barreto L, Puigdellivol M, Suelves N, Zamora-Moratalla A, Ballesteros JJ, Martin ED et al (2014) Neurotrophin receptor p75(NTR) mediates Huntington\u2019s disease-associated synaptic and memory dysfunction. J Clin Invest 124:4411\u20134428","journal-title":"Journal of Clinical Investigation"},{"key":"1126_CR29","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.1093\/hmg\/ddv218","volume":"24","author":"A Miguez","year":"2015","unstructured":"Miguez A, Garcia-Diaz Barriga G, Brito V, Straccia M, Giralt A, Gines S, Canals JM, Alberch J (2015) Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington\u2019s disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation. Hum Mol Genet 24:4958\u20134970","journal-title":"Hum Mol Genet"},{"key":"1126_CR30","unstructured":"Simmons DA, Belichenko NP, Ford EC, Semaan S, Monbureau M, Aiyaswamy S, Holman CM, Condon C et al (2016) A small molecule p75NTR ligand normalizes signalling and reduces Huntington\u2019s disease phenotypes in R6\/2 and BACHD mice. Hum Mol Genet 25:4920\u20134938"},{"issue":"25","key":"1126_CR31","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1093\/hmg\/ddv426","volume":"24","author":"Mar Puigdell\u00edvol","year":"2015","unstructured":"Puigdellivol M, Cherubini M, Brito V, Giralt A, Suelves N, Ballesteros J, Zamora-Moratalla A, Martin ED et al (2015) A role for Kalirin-7 in corticostriatal synaptic dysfunction in Huntington\u2019s disease. Hum Mol Genet 24:7265\u20137285","journal-title":"Human Molecular Genetics"},{"issue":"12","key":"1126_CR32","doi-asserted-by":"crossref","first-page":"6809","DOI":"10.1073\/pnas.120166397","volume":"97","author":"J. A. Bibb","year":"2000","unstructured":"Bibb JA, Yan Z, Svenningsson P, Snyder GL, Pieribone VA, Horiuchi A, Nairn AC, Messer A et al (2000) Severe deficiencies in dopamine signaling in presymptomatic Huntington\u2019s disease mice. Proc Natl Acad Sci U S A 97:6809\u20136814","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"10","key":"1126_CR33","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1093\/brain\/awv214","volume":"138","author":"Flavia Niccolini","year":"2015","unstructured":"Niccolini F, Haider S, Reis Marques T, Muhlert N, Tziortzi AC, Searle GE, Natesan S, Piccini P et al (2015) Altered PDE10A expression detectable early before symptomatic onset in Huntington\u2019s disease. Brain 138:3016\u20133029","journal-title":"Brain"},{"key":"1126_CR34","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.2174\/138161208784480117","volume":"14","author":"P Popoli","year":"2008","unstructured":"Popoli P, Blum D, Domenici MR, Burnouf S, Chern Y (2008) A critical evaluation of adenosine A2A receptors as potentially \u201cdruggable\u201d targets in Huntington\u2019s disease. Curr Pharm Des 14:1500\u20131511","journal-title":"Curr Pharm Des"},{"key":"1126_CR35","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1111\/j.0953-816X.2004.03374.x","volume":"19","author":"TL Spires","year":"2004","unstructured":"Spires TL, Grote HE, Garry S, Cordery PM, Van Dellen A, Blakemore C, Hannan AJ (2004) Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6\/1 Huntington\u2019s disease transgenic mice. Eur J Neurosci 19:2799\u20132807","journal-title":"Eur J Neurosci"},{"key":"1126_CR36","doi-asserted-by":"crossref","first-page":"12997","DOI":"10.1523\/JNEUROSCI.5284-12.2013","volume":"33","author":"RP Murmu","year":"2013","unstructured":"Murmu RP, Li W, Holtmaat A, Li J-Y (2013) Dendritic spine instability leads to progressive neocortical spine loss in a mouse model of Huntington\u2019s disease. J Neurosci 33:12997\u201313009","journal-title":"J Neurosci"},{"key":"1126_CR37","doi-asserted-by":"crossref","first-page":"9989","DOI":"10.1523\/JNEUROSCI.2492-05.2005","volume":"25","author":"M Zagrebelsky","year":"2005","unstructured":"Zagrebelsky M, Holz A, Dechant G, Barde Y-A, Bonhoeffer T, Korte M (2005) The p75 neurotrophin receptor negatively modulates dendrite complexity and spine density in hippocampal neurons. J Neurosci 25:9989\u20139999","journal-title":"J Neurosci"},{"issue":"2","key":"1126_CR38","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nn.2244","volume":"12","author":"Jianmin Yang","year":"2009","unstructured":"Yang J, Siao C-J, Nagappan G, Marinic T, Jing D, McGrath K, Chen Z-Y, Mark W et al (2009) Neuronal release of proBDNF. Nat Neurosci 12:113\u2013115","journal-title":"Nature Neuroscience"},{"key":"1126_CR39","doi-asserted-by":"crossref","first-page":"832.e1","DOI":"10.1016\/j.neurobiolaging.2011.07.015","volume":"33","author":"TR Chapman","year":"2012","unstructured":"Chapman TR, Barrientos RM, Ahrendsen JT, Hoover JM, Maier SF, Patterson SL (2012) Aging and infection reduce expression of specific brain-derived neurotrophic factor mRNAs in hippocampus. Neurobiol Aging 33:832.e1\u2013832.14","journal-title":"Neurobiol Aging"},{"key":"1126_CR40","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1016\/j.neurobiolaging.2013.06.014","volume":"34","author":"F Calabrese","year":"2013","unstructured":"Calabrese F, Guidotti G, Racagni G, Riva MA (2013) Reduced neuroplasticity in aged rats: a role for the neurotrophin brain-derived neurotrophic factor. Neurobiol Aging 34:2768\u20132776","journal-title":"Neurobiol Aging"},{"key":"1126_CR41","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.phrs.2005.01.001","volume":"52","author":"C Zuccato","year":"2005","unstructured":"Zuccato C, Liber D, Ramos C, Tarditi A, Rigamonti D, Tartari M, Valenza M, Cattaneo E (2005) Progressive loss of BDNF in a mouse model of Huntington\u2019s disease and rescue by BDNF delivery. Pharmacol Res 52:133\u2013139","journal-title":"Pharmacol Res"},{"key":"1126_CR42","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/39885","volume":"389","author":"CA Altar","year":"1997","unstructured":"Altar CA, Cai N, Bliven T, Juhasz M, Conner JM, Acheson AL, Lindsay RM, Wiegand SJ (1997) Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 389:856\u2013860","journal-title":"Nature"},{"key":"1126_CR43","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0896-6273(02)00942-X","volume":"36","author":"L Minichiello","year":"2002","unstructured":"Minichiello L, Calella AM, Medina DL, Bonhoeffer T, Klein R, Korte M (2002) Mechanism of TrkB-mediated hippocampal long-term potentiation. Neuron 36:121\u2013137","journal-title":"Neuron"},{"key":"1126_CR44","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1146\/annurev.biochem.72.121801.161629","volume":"72","author":"EJ Huang","year":"2003","unstructured":"Huang EJ, Reichardt LF (2003) Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem 72:609\u2013642","journal-title":"Annu Rev Biochem"},{"key":"1126_CR45","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3233\/JHD-140106","volume":"3","author":"KR Bowles","year":"2014","unstructured":"Bowles KR, Jones L (2014) Kinase signalling in Huntington\u2019s disease. J Huntingtons Dis 3:89\u2013123","journal-title":"J Huntingtons Dis"},{"issue":"2","key":"1126_CR46","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/cdd.2009.127","volume":"17","author":"A Saavedra","year":"2009","unstructured":"Saavedra A, Garcia-Martinez JM, Xifro X, Giralt A, Torres-Peraza JF, Canals JM, Diaz-Hernandez M, Lucas JJ et al (2010) PH domain leucine-rich repeat protein phosphatase 1 contributes to maintain the activation of the PI3K\/Akt pro-survival pathway in Huntington\u2019s disease striatum. Cell Death Differ 17:324\u2013335","journal-title":"Cell Death & Differentiation"},{"key":"1126_CR47","doi-asserted-by":"crossref","first-page":"50514","DOI":"10.1074\/jbc.M309348200","volume":"278","author":"S Gines","year":"2003","unstructured":"Gines S, Ivanova E, Seong I-S, Saura CA, MacDonald ME (2003) Enhanced Akt signaling is an early pro-survival response that reflects N-methyl-D-aspartate receptor activation in Huntington\u2019s disease knock-in striatal cells. J Biol Chem 278:50514\u201350522","journal-title":"J Biol Chem"},{"issue":"1","key":"1126_CR48","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mcn.2008.04.007","volume":"39","author":"Barbara L. Apostol","year":"2008","unstructured":"Apostol BL, Simmons DA, Zuccato C, Illes K, Pallos J, Casale M, Conforti P, Ramos C et al (2008) CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6\/2 mice. Mol Cell Neurosci 39:8\u201320","journal-title":"Molecular and Cellular Neuroscience"},{"key":"1126_CR49","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.expneurol.2008.10.008","volume":"215","author":"V Perrin","year":"2009","unstructured":"Perrin V, Dufour N, Raoul C, Hassig R, Brouillet E, Aebischer P, Luthi-Carter R, Deglon N (2009) Implication of the JNK pathway in a rat model of Huntington\u2019s disease. Exp Neurol 215:191\u2013200","journal-title":"Exp Neurol"},{"issue":"6","key":"1126_CR50","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1523\/JNEUROSCI.4965-11.2013","volume":"33","author":"D. M. Taylor","year":"2013","unstructured":"Taylor DM, Moser R, Regulier E, Breuillaud L, Dixon M, Beesen AA, Elliston L, de Silva Santos M, F et al (2013) MAP kinase phosphatase 1 (MKP-1\/DUSP1) is neuroprotective in Huntington\u2019s disease via additive effects of JNK and p38 inhibition. J Neurosci 33:2313\u20132325","journal-title":"Journal of Neuroscience"},{"key":"1126_CR51","doi-asserted-by":"crossref","unstructured":"Bragg RM, Coffey SR, Weston RM, Ament SA, Cantle JP, Minnig S, Funk CC, Shuttleworth DD et al (2017) Motivational, proteostatic and transcriptional deficits precede synapse loss, gliosis and neurodegeneration in the B6.HttQ111\/+ model of Huntington\u2019s disease. Sci Rep 7:41570","DOI":"10.1038\/srep41570"},{"key":"1126_CR52","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1007\/s12035-013-8556-x","volume":"49","author":"M Anglada-Huguet","year":"2014","unstructured":"Anglada-Huguet M, Xifro X, Giralt A, Zamora-Moratalla A, Martin ED, Alberch J (2014) Prostaglandin E2 EP1 receptor antagonist improves motor deficits and rescues memory decline in R6\/1 mouse model of Huntington\u2019s disease. Mol Neurobiol 49:784\u2013795","journal-title":"Mol Neurobiol"},{"key":"1126_CR53","first-page":"3144","volume":"26","author":"G Garcia-Diaz Barriga","year":"2017","unstructured":"Garcia-Diaz Barriga G, Giralt A, Anglada-Huguet M, Gaja-Capdevila N, Orlandi JG, Soriano J, Canals J-M, Alberch J (2017) 7,8-Dihydroxyflavone ameliorates cognitive and motor deficits in a Huntington\u2019s disease mouse model through specific activation of the PLCgamma1 pathway. Hum Mol Genet 26:3144\u20133160","journal-title":"Hum Mol Genet"},{"issue":"35","key":"1126_CR54","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","volume":"24","author":"J. M. Canals","year":"2004","unstructured":"Canals JM, Pineda JR, Torres-Peraza JF, Bosch M, Martin-Ibanez R, Munoz MT, Mengod G, Ernfors P et al (2004) Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington\u2019s disease. J Neurosci 24:7727\u20137739","journal-title":"Journal of Neuroscience"},{"issue":"42","key":"1126_CR55","doi-asserted-by":"crossref","first-page":"10460","DOI":"10.1523\/JNEUROSCI.2518-08.2008","volume":"28","author":"A. Nishi","year":"2008","unstructured":"Nishi A, Kuroiwa M, Miller DB, O\u2019Callaghan JP, Bateup HS, Shuto T, Sotogaku N, Fukuda T et al (2008) Distinct roles of PDE4 and PDE10A in the regulation of cAMP\/PKA signaling in the striatum. J Neurosci 28:10460\u201310471","journal-title":"Journal of Neuroscience"},{"key":"1126_CR56","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/978-3-7091-0932-8_18","volume":"970","author":"J-A Girault","year":"2012","unstructured":"Girault J-A (2012) Integrating neurotransmission in striatal medium spiny neurons. Adv Exp Med Biol 970:407\u2013429","journal-title":"Adv Exp Med Biol"},{"key":"1126_CR57","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nature11846","volume":"494","author":"G Cui","year":"2013","unstructured":"Cui G, Jun SB, Jin X, Pham MD, Vogel SS, Lovinger DM, Costa RM (2013) Concurrent activation of striatal direct and indirect pathways during action initiation. Nature 494:238\u2013242","journal-title":"Nature"},{"key":"1126_CR58","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1523\/JNEUROSCI.4454-03.2004","volume":"24","author":"MJ Diogenes","year":"2004","unstructured":"Diogenes MJ, Fernandes CC, Sebastiao AM, Ribeiro JA (2004) Activation of adenosine A2A receptor facilitates brain-derived neurotrophic factor modulation of synaptic transmission in hippocampal slices. J Neurosci 24:2905\u20132913","journal-title":"J Neurosci"},{"key":"1126_CR59","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.neuropharm.2008.01.011","volume":"54","author":"BM Fontinha","year":"2008","unstructured":"Fontinha BM, Diogenes MJ, Ribeiro JA, Sebastiao AM (2008) Enhancement of long-term potentiation by brain-derived neurotrophic factor requires adenosine A2A receptor activation by endogenous adenosine. Neuropharmacology 54:924\u2013933","journal-title":"Neuropharmacology"},{"key":"1126_CR60","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.bbamem.2010.06.028","volume":"1808","author":"AM Sebastiao","year":"2011","unstructured":"Sebastiao AM, Assaife-Lopes N, Diogenes MJ, Vaz SH, Ribeiro JA (2011) Modulation of brain-derived neurotrophic factor (BDNF) actions in the nervous system by adenosine A(2A) receptors and the role of lipid rafts. Biochim Biophys Acta 1808:1340\u20131349","journal-title":"Biochim Biophys Acta"},{"key":"1126_CR61","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1146\/annurev.pharmtox.44.101802.121415","volume":"44","author":"P Svenningsson","year":"2004","unstructured":"Svenningsson P, Nishi A, Fisone G, Girault J-A, Nairn AC, Greengard P (2004) DARPP-32: an integrator of neurotransmission. Annu Rev Pharmacol Toxicol 44:269\u2013296","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1126_CR62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.0020176","volume":"2","author":"E Fernandez","year":"2006","unstructured":"Fernandez E, Schiappa R, Girault J-A, Le Novere N (2006) DARPP-32 is a robust integrator of dopamine and glutamate signals. PLoS Comput Biol 2:e176","journal-title":"PLoS Comput Biol"},{"key":"1126_CR63","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fnbeh.2011.00056","volume":"5","author":"M Yger","year":"2011","unstructured":"Yger M, Girault J-A (2011) DARPP-32, Jack of all trades\u2026 Master of which? Front Behav Neurosci 5:56","journal-title":"Front Behav Neurosci"},{"key":"1126_CR64","doi-asserted-by":"crossref","unstructured":"Engmann O, Giralt A, Gervasi N, Marion-Poll L, Gasmi L, Filhol O, Picciotto MR, Gilligan D et al (2015) DARPP-32 interaction with adducin may mediate rapid environmental effects on striatal neurons. Nat Commun 6:10099","DOI":"10.1038\/ncomms10099"},{"key":"1126_CR65","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1093\/hmg\/ddu166","volume":"23","author":"GA Smith","year":"2014","unstructured":"Smith GA, Rocha EM, McLean JR, Hayes MA, Izen SC, Isacson O, Hallett PJ (2014) Progressive axonal transport and synaptic protein changes correlate with behavioral and neuropathological abnormalities in the heterozygous Q175 KI mouse model of Huntington\u2019s disease. Hum Mol Genet 23:4510\u20134527","journal-title":"Hum Mol Genet"},{"key":"1126_CR66","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1523\/JNEUROSCI.1658-03.2004","volume":"24","author":"TL Spires","year":"2004","unstructured":"Spires TL, Grote HE, Varshney NK, Cordery PM, van Dellen A, Blakemore C, Hannan AJ (2004) Environmental enrichment rescues protein deficits in a mouse model of Huntington\u2019s disease, indicating a possible disease mechanism. J Neurosci 24:2270\u20132276","journal-title":"J Neurosci"},{"key":"1126_CR67","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1093\/hmg\/ddn281","volume":"17","author":"D Zala","year":"2008","unstructured":"Zala D, Colin E, Rangone H, Liot G, Humbert S, Saudou F (2008) Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons. Hum Mol Genet 17:3837\u20133846","journal-title":"Hum Mol Genet"},{"key":"1126_CR68","doi-asserted-by":"crossref","first-page":"21205","DOI":"10.1074\/jbc.M114.563403","volume":"289","author":"BR Kraemer","year":"2014","unstructured":"Kraemer BR, Snow JP, Vollbrecht P, Pathak A, Valentine WM, Deutch AY, Carter BD (2014) A role for the p75 neurotrophin receptor in axonal degeneration and apoptosis induced by oxidative stress. J Biol Chem 289:21205\u201321216","journal-title":"J Biol Chem"},{"issue":"18","key":"1126_CR69","doi-asserted-by":"publisher","first-page":"5285","DOI":"10.1093\/hmg\/ddv248","volume":"24","author":"Rodolfo G. Gatto","year":"2015","unstructured":"Gatto RG, Chu Y, Ye AQ, Price SD, Tavassoli E, Buenaventura A, Brady ST, Magin RL et al (2015) Analysis of YFP(J16)-R6\/2 reporter mice and postmortem brains reveals early pathology and increased vulnerability of callosal axons in Huntington\u2019s disease. Hum Mol Genet England 24:5285\u20135298. \nhttps:\/\/doi.org\/10.1093\/hmg\/ddv248","journal-title":"Human Molecular Genetics"},{"key":"1126_CR70","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.expneurol.2012.08.010","volume":"246","author":"J-Y Li","year":"2013","unstructured":"Li J-Y, Conforti L (2013) Axonopathy in Huntington\u2019s disease. Exp Neurol 246:62\u201371","journal-title":"Exp Neurol"},{"key":"1126_CR71","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1359-6101(01)00024-7","volume":"13","author":"FS Lee","year":"2002","unstructured":"Lee FS, Rajagopal R, Chao MV (2002) Distinctive features of Trk neurotrophin receptor transactivation by G protein-coupled receptors. Cytokine Growth Factor Rev 13:11\u201317","journal-title":"Cytokine Growth Factor Rev"},{"key":"1126_CR72","doi-asserted-by":"crossref","first-page":"6650","DOI":"10.1523\/JNEUROSCI.0010-04.2004","volume":"24","author":"R Rajagopal","year":"2004","unstructured":"Rajagopal R, Chen Z-Y, Lee FS, Chao MV (2004) Transactivation of Trk neurotrophin receptors by G-protein-coupled receptor ligands occurs on intracellular membranes. J Neurosci 24:6650\u20136658","journal-title":"J Neurosci"},{"issue":"52","key":"1126_CR73","doi-asserted-by":"crossref","first-page":"19115","DOI":"10.1073\/pnas.0509494102","volume":"102","author":"P. Berghuis","year":"2005","unstructured":"Berghuis P, Dobszay MB, Wang X, Spano S, Ledda F, Sousa KM, Schulte G, Ernfors P et al (2005) Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor. Proc Natl Acad Sci U S A 102:19115\u201319120","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"4","key":"1126_CR74","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1124\/mol.105.020255","volume":"69","author":"Martin A. Lewis","year":"2006","unstructured":"Lewis MA, Hunihan L, Franco D, Robertson B, Palmer J, Laurent DRS, Balasubramanian BN, Li Y et al (2006) Identification and characterization of compounds that potentiate NT-3-mediated Trk receptor activity. Mol Pharmacol 69:1396\u20131404","journal-title":"Molecular Pharmacology"},{"key":"1126_CR75","doi-asserted-by":"crossref","first-page":"24414","DOI":"10.1074\/jbc.M001641200","volume":"275","author":"J Vesa","year":"2000","unstructured":"Vesa J, Kruttgen A, Shooter EM (2000) p75 reduces TrkB tyrosine autophosphorylation in response to brain-derived neurotrophic factor and neurotrophin 4\/5. J Biol Chem 275:24414\u201324420","journal-title":"J Biol Chem"},{"key":"1126_CR76","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1038\/srep03185","volume":"3","author":"S Sakuragi","year":"2013","unstructured":"Sakuragi S, Tominaga-Yoshino K, Ogura A (2013) Involvement of TrkB- and p75(NTR)-signaling pathways in two contrasting forms of long-lasting synaptic plasticity. Sci Rep 3:3185","journal-title":"Sci Rep"},{"key":"1126_CR77","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/emboj\/18.3.616","volume":"18","author":"M Bibel","year":"1999","unstructured":"Bibel M, Hoppe E, Barde YA (1999) Biochemical and functional interactions between the neurotrophin receptors trk and p75NTR. EMBO J 18:616\u2013622","journal-title":"EMBO J"},{"key":"1126_CR78","doi-asserted-by":"crossref","unstructured":"Jang H-J, Yang YR, Kim JK, Choi JH, Seo Y-K, Lee YH, Lee JE, Ryu SH et al (2013) Phospholipase C-gamma1 involved in brain disorders. Adv Biol Regul 53:51\u201362","DOI":"10.1016\/j.jbior.2012.09.008"},{"key":"1126_CR79","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1046\/j.1471-4159.2001.00651.x","volume":"79","author":"A Stroppolo","year":"2001","unstructured":"Stroppolo A, Guinea B, Tian C, Sommer J, Ehrlich ME (2001) Role of phosphatidylinositide 3-kinase in brain-derived neurotrophic factor-induced DARPP-32 expression in medium size spiny neurons in vitro. J Neurochem 79:1027\u20131032","journal-title":"J Neurochem"},{"key":"1126_CR80","doi-asserted-by":"crossref","first-page":"14331","DOI":"10.1074\/jbc.M413279200","volume":"280","author":"M-C Chiang","year":"2005","unstructured":"Chiang M-C, Lee Y-C, Huang C-L, Chern Y (2005) cAMP-response element-binding protein contributes to suppression of the A2A adenosine receptor promoter by mutant huntingtin with expanded polyglutamine residues. J Biol Chem 280:14331\u201314340","journal-title":"J Biol Chem"},{"key":"1126_CR81","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1523\/JNEUROSCI.4340-06.2007","volume":"27","author":"EA Horne","year":"2007","unstructured":"Horne EA, Dell\u2019Acqua ML (2007) Phospholipase C is required for changes in postsynaptic structure and function associated with NMDA receptor-dependent long-term depression. J Neurosci 27:3523\u20133534","journal-title":"J Neurosci"},{"key":"1126_CR82","doi-asserted-by":"crossref","unstructured":"Zhou L, Martinez SJ, Haber M, Jones EV, Bouvier D, Doucet G, Corera AT, Fon EA et al (2007) EphA4 signaling regulates phospholipase Cgamma1 activation, cofilin membrane association, and dendritic spine morphology. J Neurosci 27:5127\u20135138","DOI":"10.1523\/JNEUROSCI.1170-07.2007"},{"key":"1126_CR83","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1471-4159.2009.06499.x","volume":"112","author":"K Kim","year":"2010","unstructured":"Kim K, Yang J, Kim E (2010) Diacylglycerol kinases in the regulation of dendritic spines. J Neurochem 112:577\u2013587","journal-title":"J Neurochem"},{"key":"1126_CR84","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1083\/jcb.153.4.851","volume":"153","author":"AB Meriin","year":"2001","unstructured":"Meriin AB, Mabuchi K, Gabai VL, Yaglom JA, Kazantsev A, Sherman MY (2001) Intracellular aggregation of polypeptides with expanded polyglutamine domain is stimulated by stress-activated kinase MEKK1. J Cell Biol 153:851\u2013864","journal-title":"J Cell Biol"},{"key":"1126_CR85","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/hmg\/ddg151","volume":"12","author":"KJ Cowan","year":"2003","unstructured":"Cowan KJ, Diamond MI, Welch WJ (2003) Polyglutamine protein aggregation and toxicity are linked to the cellular stress response. Hum Mol Genet 12:1377\u20131391","journal-title":"Hum Mol Genet"},{"key":"1126_CR86","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/hmg\/ddm134","volume":"16","author":"E Scappini","year":"2007","unstructured":"Scappini E, Koh T-W, Martin NP, O\u2019Bryan JP (2007) Intersectin enhances huntingtin aggregation and neurodegeneration through activation of c-Jun-NH2-terminal kinase. Hum Mol Genet 16:1862\u20131871","journal-title":"Hum Mol Genet"},{"issue":"7","key":"1126_CR87","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nn.2346","volume":"12","author":"Gerardo A Morfini","year":"2009","unstructured":"Morfini GA, You Y-M, Pollema SL, Kaminska A, Liu K, Yoshioka K, Bjorkblom B, Coffey ET, Bagnato C, Han D, Huang C-F, Banker G, Pigino G, et al. Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin. Nat Neurosci. United States; 2009; 12: 864\u201371. doi: \nhttps:\/\/doi.org\/10.1038\/nn.2346\n\n.","journal-title":"Nature Neuroscience"},{"key":"1126_CR88","doi-asserted-by":"crossref","first-page":"13153","DOI":"10.1074\/jbc.M809229200","volume":"284","author":"PO Bauer","year":"2009","unstructured":"Bauer PO, Wong HK, Oyama F, Goswami A, Okuno M, Kino Y, Miyazaki H, Nukina N (2009) Inhibition of rho kinases enhances the degradation of mutant huntingtin. J Biol Chem 284:13153\u201313164","journal-title":"J Biol Chem"},{"key":"1126_CR89","doi-asserted-by":"crossref","first-page":"747","DOI":"10.4161\/auto.5.5.8704","volume":"5","author":"PO Bauer","year":"2009","unstructured":"Bauer PO, Nukina N (2009) Enhanced degradation of mutant huntingtin by rho kinase inhibition is mediated through activation of proteasome and macroautophagy. Autophagy 5:747\u2013748","journal-title":"Autophagy"},{"key":"1126_CR90","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.nbd.2009.06.011","volume":"36","author":"M Li","year":"2009","unstructured":"Li M, Huang Y, Ma AAK, Lin E, Diamond MI (2009) Y-27632 improves rotarod performance and reduces huntingtin levels in R6\/2 mice. Neurobiol Dis 36:413\u2013420","journal-title":"Neurobiol Dis"},{"key":"1126_CR91","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fnins.2015.00198","volume":"9","author":"N Hensel","year":"2015","unstructured":"Hensel N, Rademacher S, Claus P (2015) Chatting with the neighbors: crosstalk between rho-kinase (ROCK) and other signaling pathways for treatment of neurological disorders. Front Neurosci 9:198","journal-title":"Front Neurosci"},{"key":"1126_CR92","doi-asserted-by":"crossref","first-page":"14230","DOI":"10.1073\/pnas.1206093109","volume":"109","author":"R Deogracias","year":"2012","unstructured":"Deogracias R, Yazdani M, Dekkers MPJ, Guy J, Ionescu MCS, Vogt KE, Barde Y-A (2012) Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome. Proc Natl Acad Sci U S A 109:14230\u201314235","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1126_CR93","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1093\/hmg\/ddt615","volume":"23","author":"A Pardo Di","year":"2014","unstructured":"Di Pardo A, Amico E, Favellato M, Castrataro R, Fucile S, Squitieri F, Maglione V (2014) FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease. Hum Mol Genet 23:2251\u20132265","journal-title":"Hum Mol Genet"},{"key":"1126_CR94","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.neuroscience.2006.04.013","volume":"141","author":"TYC Pang","year":"2006","unstructured":"Pang TYC, Stam NC, Nithianantharajah J, Howard ML, Hannan AJ (2006) Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in Huntington\u2019s disease transgenic mice. Neuroscience 141:569\u2013584","journal-title":"Neuroscience"},{"key":"1126_CR95","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nn.3728","volume":"17","author":"NC Hait","year":"2014","unstructured":"Hait NC, Wise LE, Allegood JC, O\u2019Brien M, Avni D, Reeves TM, Knapp PE, Lu J et al (2014) Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memory. Nat Neurosci 17:971\u2013980","journal-title":"Nat Neurosci"},{"key":"1126_CR96","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.tins.2007.11.005","volume":"31","author":"AB Cragnolini","year":"2008","unstructured":"Cragnolini AB, Friedman WJ (2008) The function of p75NTR in glia. Trends Neurosci 31:99\u2013104","journal-title":"Trends Neurosci"},{"key":"1126_CR97","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/glia.20857","volume":"57","author":"AB Cragnolini","year":"2009","unstructured":"Cragnolini AB, Huang Y, Gokina P, Friedman WJ (2009) Nerve growth factor attenuates proliferation of astrocytes via the p75 neurotrophin receptor. Glia 57:1386\u20131392","journal-title":"Glia"},{"key":"1126_CR98","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1111\/j.1471-4159.2010.06672.x","volume":"113","author":"I Han","year":"2010","unstructured":"Han I, You Y, Kordower JH, Brady ST, Morfini GA (2010) Differential vulnerability of neurons in Huntington\u2019s disease: the role of cell type-specific features. J Neurochem England 113:1073\u20131091. \nhttps:\/\/doi.org\/10.1111\/j.1471-4159.2010.06672.x","journal-title":"J Neurochem England"},{"issue":"1","key":"1126_CR99","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/hmg\/8.1.115","volume":"8","author":"V. Wheeler","year":"1999","unstructured":"Wheeler VC, Auerbach W, White JK, Srinidhi J, Auerbach A, Ryan A, Duyao MP, Vrbanac V et al (1999) Length-dependent gametic CAG repeat instability in the Huntington\u2019s disease knock-in mouse. Hum Mol Genet 8:115\u2013122","journal-title":"Human Molecular Genetics"},{"issue":"3","key":"1126_CR100","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"Laura Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y et al (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493\u2013506","journal-title":"Cell"},{"key":"1126_CR101","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1046\/j.1471-4159.1999.0721930.x","volume":"72","author":"R Kolbeck","year":"1999","unstructured":"Kolbeck R, Bartke I, Eberle W, Barde YA (1999) Brain-derived neurotrophic factor levels in the nervous system of wild-type and neurotrophin gene mutant mice. J Neurochem 72:1930\u20131938","journal-title":"J Neurochem"},{"key":"1126_CR102","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1046-2023(03)00009-4","volume":"30","author":"J Grutzendler","year":"2003","unstructured":"Grutzendler J, Tsai J, Gan W-B (2003) Rapid labeling of neuronal populations by ballistic delivery of fluorescent dyes. Methods 30:79\u201385","journal-title":"Methods"},{"issue":"12","key":"1126_CR103","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1093\/hmg\/ddl125","volume":"15","author":"Alejandro Lloret","year":"2006","unstructured":"Lloret A, Dragileva E, Teed A, Espinola J, Fossale E, Gillis T, Lopez E, Myers RH et al (2006) Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington\u2019s disease knock-in mice. Hum Mol Genet 15:2015\u20132024","journal-title":"Human Molecular Genetics"},{"issue":"10","key":"1126_CR104","doi-asserted-by":"crossref","first-page":"e1003930","DOI":"10.1371\/journal.pgen.1003930","volume":"9","author":"Ricardo Mouro Pinto","year":"2013","unstructured":"Pinto RM, Dragileva E, Kirby A, Lloret A, Lopez E, St Claire J, Panigrahi GB, Hou C et al (2013) Mismatch repair genes Mlh1 and Mlh3 modify CAG instability in Huntington\u2019s disease mice: genome-wide and candidate approaches. PLoS Genet 9:e1003930","journal-title":"PLoS Genetics"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-1126-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-018-1126-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-1126-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T05:26:15Z","timestamp":1579843575000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-018-1126-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,27]]},"references-count":104,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["1126"],"URL":"https:\/\/doi.org\/10.1007\/s12035-018-1126-5","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,27]]},"assertion":[{"value":"13 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Experimental procedures were approved by the Local Ethical Committee of the University of Barcelona (99\/01) and the Generalitat de Catalunya (00\/1094), following European (2010\/63\/UE) and Spanish (RD 1201\/2005) regulations for the care and use of laboratory animals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}